WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on: November 15,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on:November 15,2024

Maternal death statistics skewed by COVID, not decreased by end of Roe v. Wade: Study

by Lisa Marshall,University of Colorado at BoulderCredit: Unsplash/CC0 Public DomainFederal statistics suggesting that maternal mortality rates plummeted after the overturning of Roe v. Wade are

Updated on: September 04,2024

Maternal death statistics skewed by COVID, not decreased by end of Roe v. Wade: Study

by Lisa Marshall,University of Colorado at BoulderCredit: Unsplash/CC0 Public DomainFederal statistics suggesting that maternal mortality rates plummeted after the overturning of Roe v. Wade are

Updated on:September 04,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on: April 30,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on:April 30,2024

A newly discovered mechanism allows the immune system to detect and respond to HIV

by Norwegian University of Science and TechnologyThis graphic shows how HIV can get trapped in an endosome, or pocket, on a CD4+T cell (centre cell). Researchers previously thought this was a dea

Updated on: March 25,2024

A newly discovered mechanism allows the immune system to detect and respond to HIV

by Norwegian University of Science and TechnologyThis graphic shows how HIV can get trapped in an endosome, or pocket, on a CD4+T cell (centre cell). Researchers previously thought this was a dea

Updated on:March 25,2024

India Endures a Scorching 52.9°C Heatwave

Updated on: June 05,2024

India Endures a Scorching 52.9°C Heatwave

Updated on:June 05,2024

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on: March 20,2024

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on:March 20,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on: April 22,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on:April 22,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on: April 12,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on:April 12,2024

Junk food, sugar and additives - The dark side of the food industry | DW Documentary

Updated on: September 07,2024

Junk food, sugar and additives - The dark side of the food industry | DW Documentary

Updated on:September 07,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on: April 10,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on:April 10,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on: October 21,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on:October 21,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on: November 29,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on:November 29,2024